2023-05-22 08:06
(18 d 11:26 ago)

Posting: # 23563
Views: 213

 regulatory guideline [Regulatives / Guidelines]

In bioequivalence study if any adverse event is ongoing; we can collect safety sample or end study sample before completion of adverse event. if any reference guideline pls show
UA Flag
 Admin contact
22,627 posts in 4,743 threads, 1,613 registered users;
13 visitors (0 registered, 13 guests [including 6 identified bots]).
Forum time: 19:33 CEST (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz